title: Fluoxetine as an adjunct to conventional antipsychotic treatment of schizophrenia patients with residual symptoms.
authors.affiliation: Maryland Psychiatric Research Center, University of Maryland, Baltimore 21228, USA.
authors.forename: C
authors.initials: C
authors.lastname: Arango
authors.forename: B
authors.initials: B
authors.lastname: Kirkpatrick
authors.forename: R W
authors.initials: RW
authors.lastname: Buchanan
mesh_terms: D000328:Adult; D000553:Ambulatory Care; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D005473:Fluoxetine; D010919:Placebos; D017367:Selective Serotonin Reuptake Inhibitors